Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spydasilk Enterprises is a Singapore-based joint venture formed in 2021 to market and sell products made from Kraig Biocraft Laboratories' recombinant spider silk materials. The company appears to operate primarily as a commercialization and brand vehicle rather than a therapeutic biotech developer, with a focus on premium apparel and related spider-silk-based consumer products. Public disclosures indicate that it was established by Kraig Biocraft Laboratories together with Kings Golden Harvest, with references also naming M the Movement in the formation announcement. Spydasilk has been associated with the SpydaSilk brand and with exclusive commercialization rights in the ASEAN region for certain spider-silk-based products. Based on the available evidence, it is an active company in advanced biomaterials and apparel commercialization, not a life science or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spydasilk Enterprises.